Flexion Therapeutics is recalling 792 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial. The medication was stored at room temperature for longer than the recommended six-week limit and was accidentally distributed instead of being destroyed. This drug is an injectable medication used for osteoarthritis pain, and consumers should contact their healthcare provider if they have received treatment from the affected lot.
The product was exposed to room temperatures for an excessive period, which may affect the stability or effectiveness of the medication. Using medication that has been improperly stored could result in a reduced therapeutic effect for the patient.
Guidance and refund for unused medication
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.